American Leprosy Missions Welcomes New International Staff Member
(Greenville, S.C., August 16, 2017) — The United States’ leading anti-leprosy organization is adding to its field staff with the hiring of a new regional director for Africa. Joining American Leprosy Missions’ work of bringing hope and healing to people suffering from leprosy and related diseases is George Gitau of Kenya. He has more than 30 years of experience in sustainable development, strategic planning and operations management.
“George brings extensive leadership experience in global development to the American Leprosy Missions team,” said Darren Schaupp, vice president of programs. “He has a successful track record of growing complex and innovative programs across Africa. We look forward to having his leadership in the Africa region as we grow to serve the millions of people affected by Neglected Tropical Diseases.”
Gitau comes to the organization after seven years as Rwanda national director for World Vision International where he started new partnerships, developed a grants acquisition and management system and doubled revenue. From 1997 to 2010, Gitau worked for Compassion International as Kenya country director, Burkina Faso country director and complementary interventions director (East and West Africa). In these roles he built a grants portfolio, started innovative programs for children and youth leadership, and launched the first country office in West Africa. Gitau has a master’s degree in public and international affairs from the University of Pittsburgh in Pennsylvania. He and his family will be based in Kenya.
About American Leprosy Missions
American Leprosy Missions, based in Greenville, South Carolina, is the oldest and largest Christian organization in the United States dedicated to curing and caring for people affected by leprosy and related diseases. It currently supports projects and partners in countries across Africa, Asia and the Americas. Since its founding in 1906, American Leprosy Missions has provided holistic care to more than four million people around the world including medical treatment and training, community development and vaccine research.
For Additional Information